A comparative study of Sitagliptin- Glimepiride combinational therapy and Glimepiride monotherapy on the patients with diabetes mellitus after pancreatic biliary diseases including malignant disorders related subtotal pancreatectomy - A comparative study of Sitagliptin- Glimepiride combinational therapy and Glimepiride monotherapy on the patients with diabetes mellitus after subtotal pancreatectomy

Hiroshima University Hospital Department of Endocrinology and Diabetes mellitus0 个研究点目标入组 60 人开始时间: 2010年12月2日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(a) Patients with a history of total pancreatectomy. (b) Patients with insulin-dependent diabetes mellitus. (c) Patients with a history of severe cardiovascular or cerebrovascular disease or renal failure. (c) Patients have contraindication of Sitagliptin, Glimepiride and glucagon. (d) Patients with severe liver damage. (e) Patients are pregnant or patients breast-feeding, potentially pregnant. (f) Patients who are diagnosed to be ineligible by the investigator.

发起方

Hiroshima University Hospital Department of Endocrinology and Diabetes mellitus